Free Trial
OTCMKTS:TMED

Trimedyne (TMED) Stock Price, News & Analysis

Trimedyne logo
$24.30 -0.11 (-0.45%)
As of 06/20/2025 09:47 AM Eastern

About Trimedyne Stock (OTCMKTS:TMED)

Key Stats

Today's Range
$24.30
$24.41
50-Day Range
$4.25
$25.13
52-Week Range
$24.30
$25.26
Volume
111 shs
Average Volume
3,742 shs
Market Capitalization
$2.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.

Receive TMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter.

TMED Stock News Headlines

EGF Theramed Health Corp. (TMED.CN)
See More Headlines

TMED Stock Analysis - Frequently Asked Questions

Trimedyne's stock was trading at $4.25 at the beginning of 2025. Since then, TMED stock has increased by 471.8% and is now trading at $24.30.
View the best growth stocks for 2025 here
.

Trimedyne, Inc. (OTCMKTS:TMED) released its quarterly earnings data on Tuesday, February, 20th. The technology company reported $0.70 earnings per share for the quarter. The technology company had revenue of $1.53 million for the quarter.

Shares of TMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trimedyne investors own include Aflac (AFL), Incyte (INCY), Martin Marietta Materials (MLM), National Fuel Gas (NFG), PDC Energy (PDCE), Snap (SNAP) and Agilent Technologies (A).

Company Calendar

Last Earnings
2/20/2018
Today
6/22/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:TMED
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.99 million
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (OTCMKTS:TMED) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners